Evidence map›Paper›PMID 27437087›Full record

ArticleToxicological research2016

Inhibition of Cytochrome P450 by Propolis in Human Liver Microsomes.

Chang Seon Ryu, Soo Jin Oh, Jung Min Oh, Ji-Yoon Lee, Sang Yoon Lee, Jung-Woo Chae, Kwang-Il Kwon, Sang Kyum Kim

Open access · hybridAbstract read
In one paragraph

Article in Toxicological research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Chang Seon RyuCollege of Pharmacy, Chungnam National University, Daejeon, Korea.
Soo Jin OhBio-Evaluation Center, Korea Research Institute of Bioscience and Biotechnology, Ochang, Korea.
Jung Min OhCollege of Pharmacy, Chungnam National University, Daejeon, Korea.
Ji-Yoon LeeCollege of Pharmacy, Chungnam National University, Daejeon, Korea.
Sang Yoon LeeCollege of Pharmacy, Chungnam National University, Daejeon, Korea.
Jung-Woo ChaeCollege of Pharmacy, Chungnam National University, Daejeon, Korea.
Kwang-Il KwonCollege of Pharmacy, Chungnam National University, Daejeon, Korea.
Sang Kyum KimCollege of Pharmacy, Chungnam National University, Daejeon, Korea.
Chungnam National University · KRKorea Research Institute of Bioscience and Biotechnology · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although propolis is one of the most popular functional foods for human health, there have been no comprehensive studies of herb-drug interactions through cytochrome P450 (CYP) inhibition. The purpose of this study was to determine the inhibitory effects of propolis on the activities of CYP1A2, 2A6, 2B6, 2C9, 2C19, 2D6, 2E1 and 3A4 using pooled human liver microsomes (HLMs). Propolis inhibited CYP1A2, CYP2E1 and CYP2C19 with an IC50 value of 6.9, 16.8, and 43.1 μg/mL, respectively, whereas CYP2A6, 2B6, 2C9, 2D6, and 3A4 were unaffected. Based on half-maximal inhibitory concentration shifts between microsomes incubated with and without nicotinamide adenine dinucleotide phosphate, propolis-induced CYP1A2, CYP2C19, and CYP2E1 inhibition was metabolism-independent. To evaluate the interaction potential between propolis and therapeutic drugs, the effects of propolis on metabolism of duloxetine, a serotonin-norepinephrine reuptake inhibitor, were determined in HLMs. CYP1A2 and CYP2D6 are involved in hydroxylation of duloxetine to 4-hydroxy duloxetine, the major metabolite, which was decreased following propolis addition in HLMs. These results raise the possibility of interactions between propolis and therapeutic drugs metabolized by CYP1A2.

Indexed as

Cytochrome P450Drug-drug interactionDuloxetinePropolis

Identifiers

PMID27437087
PMCPMC4946414
OpenAlexW2462097670

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.